EQ Wealth Advisors LLC lessened its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 99.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 506 shares of the enterprise software provider's stock after selling 75,933 shares during the quarter. EQ Wealth Advisors LLC's holdings in Oracle were worth $111,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Oracle by 71.6% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock worth $35,984,000 after purchasing an additional 107,404 shares during the period. Lockheed Martin Investment Management Co. lifted its stake in shares of Oracle by 4.3% in the first quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider's stock worth $7,179,000 after buying an additional 2,110 shares in the last quarter. Cascade Investment Group Inc. bought a new position in shares of Oracle in the second quarter worth approximately $239,000. Lockerman Financial Group Inc. bought a new position in shares of Oracle in the second quarter worth approximately $328,000. Finally, Elser Financial Planning Inc bought a new position in shares of Oracle in the second quarter worth approximately $1,066,000. Hedge funds and other institutional investors own 42.44% of the company's stock.
Oracle Stock Down 2.8%
Shares of Oracle stock opened at $299.33 on Wednesday. The company has a market cap of $853.32 billion, a price-to-earnings ratio of 69.29, a price-to-earnings-growth ratio of 3.31 and a beta of 1.53. The company's 50 day moving average is $268.67 and its 200 day moving average is $212.52. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.
Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter last year, the company earned $1.39 EPS. The firm's revenue for the quarter was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Research analysts anticipate that Oracle Corporation will post 5 EPS for the current year.
Oracle Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be given a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle's dividend payout ratio (DPR) is presently 46.30%.
Insiders Place Their Bets
In other Oracle news, Director Naomi O. Seligman sold 2,222 shares of the stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $288.91, for a total value of $641,958.02. Following the transaction, the director directly owned 29,225 shares in the company, valued at approximately $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Clayton M. Magouyrk sold 21,241 shares of the stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the transaction, the insider owned 78,000 shares in the company, valued at $23,174,580. The trade was a 21.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 120,769 shares of company stock valued at $36,428,967. 40.90% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the stock. Mizuho upped their target price on shares of Oracle from $300.00 to $350.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 10th. Melius Research upped their target price on shares of Oracle from $270.00 to $370.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. Bank of America upgraded shares of Oracle from a "neutral" rating to a "buy" rating and upped their target price for the stock from $295.00 to $368.00 in a research note on Wednesday, September 10th. Wolfe Research upped their target price on shares of Oracle from $300.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 10th. Finally, Weiss Ratings upgraded shares of Oracle from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $307.00.
Get Our Latest Research Report on Oracle
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.